These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 6326166)

  • 21. Effect of alpha-methyldopa on dopamine synthesis and release in rat striatum in vitro.
    Uretsky NJ; Chase GJ; Lorenzo AV
    J Pharmacol Exp Ther; 1975 Apr; 193(1):73-87. PubMed ID: 237116
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Unusual alpha adrenergic receptor potency of methyldopa metabolites on melanocyte function.
    Pettinger WA
    J Pharmacol Exp Ther; 1977 Jun; 201(3):622-6. PubMed ID: 16998
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multiple apparent alpha-noradrenergic receptor binding sites in rat brain: effect of 6-hydroxydopamine.
    U'Prichard DC; Bechtel WD; Rouot BM; Snyder SH
    Mol Pharmacol; 1979 Jul; 16(1):47-60. PubMed ID: 39248
    [No Abstract]   [Full Text] [Related]  

  • 24. Effects of methyldopa metabolites on amine transmitters and adrenergic receptors in rat brain.
    Louis WJ; Conway E; Summers R; Beart P; Jarrott B
    Hypertension; 1984; 6(5 Pt 2):II40-4. PubMed ID: 6094348
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Role of alpha-sympathomimetic agents in the central nervous system. Study of the central effects of adrenergic drugs by injection into the vertebral artery].
    Van Zwieten PA
    Therapie; 1972; 27(4):565-75. PubMed ID: 4404301
    [No Abstract]   [Full Text] [Related]  

  • 26. Effects of subacute treatment with toluene on cerebrocortical alpha- and beta-adrenergic receptors in the rat. Evidence for an increased number and a reduced affinity of beta-adrenergic receptors.
    Fuxe K; Martire M; von Euler G; Agnati LF; Hansson T; Andersson K; Gustafsson JA; Härfstrand A
    Acta Physiol Scand; 1987 Jun; 130(2):307-11. PubMed ID: 3037856
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuroleptic drug interactions with norepinephrine alpha receptor binding sites in rat brain.
    Peroutka SJ; U'Prichard DC; Greenberg DA; Snyder SH
    Neuropharmacology; 1977 Sep; 16(9):549-56. PubMed ID: 21357
    [No Abstract]   [Full Text] [Related]  

  • 28. Mechanism of the tachycardia following systemic alpha-methyldopa administration in conscious rats.
    van der Maas ML; Head GA; de Jong W
    J Cardiovasc Pharmacol; 1986; 8(5):1014-9. PubMed ID: 2429074
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Specific binding of 3H-guanfacine to alpha 2-adrenoceptors in rat brain. Comparison with 3H-clonidine.
    Dausse JP; Cardot A; Meyer P
    J Pharmacol; 1983; 14(1):35-46. PubMed ID: 6300560
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regional variations in alpha adrenergic receptor interactions of [3H]-dihydroergokryptine in calf brain: implications for a two-site model of alpha receptor function.
    Peroutka SJ; Greenberg DA; U'Prichard DC; Snyder SH
    Mol Pharmacol; 1978 May; 14(3):403-12. PubMed ID: 26861
    [No Abstract]   [Full Text] [Related]  

  • 31. Pharmacological evidence for alpha-2 adrenoceptor heterogeneity: differential binding properties of [3H]rauwolscine and [3H]idazoxan in rat brain.
    Boyajian CL; Leslie FM
    J Pharmacol Exp Ther; 1987 Jun; 241(3):1092-8. PubMed ID: 2885406
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effect of the chronic use of propranolol on the specific binding of 3H-WB-4101 with the membranes of the mesenteric vessels in rats].
    Ismailov ShI; Rozhanets VV; Val'dman AV
    Biull Eksp Biol Med; 1985 Jul; 100(7):38-40. PubMed ID: 2861863
    [TBL] [Abstract][Full Text] [Related]  

  • 33. On the role of the central noradrenergic and dopaminergic systems in the regulation of TSH secretion in the rat.
    Krulich L; Giachetti A; Marchlewska-Koj A; Hefco E; Jameson HE
    Endocrinology; 1977 Feb; 100(2):496-505. PubMed ID: 188629
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of central alpha-adrenoceptors using 3H-clonidine and its derivatives.
    Jarrott B; Louis WJ; Summers RJ
    Chest; 1983 Feb; 83(2 Suppl):339-40. PubMed ID: 6129948
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulation in the central norepinephrine neurotransmission induced in vivo by alpha adrenoceptor active drugs.
    Braestrup C; Nielsen M
    J Pharmacol Exp Ther; 1976 Sep; 198(3):596-608. PubMed ID: 185355
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anatomical evidence for alpha-2 adrenoceptor heterogeneity: differential autoradiographic distributions of [3H]rauwolscine and [3H]idazoxan in rat brain.
    Boyajian CL; Loughlin SE; Leslie FM
    J Pharmacol Exp Ther; 1987 Jun; 241(3):1079-91. PubMed ID: 3037066
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Discrimination and pharmacological characterization of I2-imidazoline sites with [3H]idazoxan and alpha-2 adrenoceptors with [3H]RX821002 (2-methoxy idazoxan) in the human and rat brains.
    Miralles A; Olmos G; Sastre M; Barturen F; Martin I; Garcia-Sevilla JA
    J Pharmacol Exp Ther; 1993 Mar; 264(3):1187-97. PubMed ID: 8095548
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quantitative analysis of the localization of adrenergic binding sites in chick brain.
    Dermon CR; Kouvelas ED
    J Neurosci Res; 1989 Jul; 23(3):297-303. PubMed ID: 2769794
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interactions of divalent cations and guanine nucleotides at alpha 2-noradrenergic receptor binding sites in bovine brain mechanisms.
    U'Prichard DC; Snyder SH
    J Neurochem; 1980 Feb; 34(2):385-94. PubMed ID: 6251167
    [No Abstract]   [Full Text] [Related]  

  • 40. Effects of catecholaminergic drugs upon memory storage processes in mice.
    Haycock JW; Van Buskirk R; McGaugh JL
    Behav Biol; 1977 Jul; 20(3):281-310. PubMed ID: 19010
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.